Skip to main content
. 2019 Mar 22;17(5):4013–4022. doi: 10.3892/etm.2019.7428

Table IV.

Testosterone levels at the end of the study.

Groups Median IQR Differences from 21th daya
Sham (n=9) 1.22 0.66 Z=0.415; P=0.678
PCOS control (n=9) 4.88 0.65 Z=2.547; P=0.011
Merformin (n=8) 1.67 0.36 Z=2.521; P=0.012
Metformin + PDE4i (n=10) 1.05 0.22 Z=2.803; P=0.005
a

Wilcoxon signed rank test results. IQR, interquartile range; PCOS, polycystic ovary syndrome; PDE4i, phosphodiesterase 4 inhibitor.